Our group previously reported that a G2M checkpoint and E2F target pathway score, both of which are genes essential to the cell cycle, predicted NAC response as well as prognosis in ER-positive/HER2-negative breast cancer but not in TNBC [17,18]. Here, ERBB2 is linked to breast cancer.